Home » Topics » Regulatory

Regulatory
RSS

Raptiva approved for chronic, moderate to severe plaque psoriasis

Oct. 30, 2003

Levaquin approved for five-day treatment of CAP

Oct. 30, 2003

Cyberonics submits PMA-S for VNS Therapy

Oct. 29, 2003

Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease

Oct. 27, 2003

Starlix approved in combination with TZD for type 2 diabetes

Oct. 27, 2003

Approvable letter issued for Foradil Certihaler

Oct. 24, 2003

Approvable letter issued for expansion of Provigil labeling

Oct. 23, 2003

Once-weekly Enbrel approved

Oct. 23, 2003

Lexiva, the only protease inhibitor offering flexible dosing, approved in U.S.

Oct. 22, 2003

Paxil CR approved for social anxiety disorder

Oct. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...